Thnx #ProfDavidSinclair & @thecrimson @Harvard for article on #AgingReversal
https://www.thecrimson.com/
&
corey.becker@thecrimson.com
Interesting to see you #CoreyBeckerHarvardPhysics that you went to the Quaker @FriendsSelect_ '22 How could Quaker informed free @WorldUnivAndSch - https://wiki.
* * * *
Thnx @geochurch for retweet & re "Nabla Bio’s AI design AND human-relevant wet-lab capabilities" &
"Nabla Bio’s AI design and human-relevant wet-lab capabilities" to deploy "across Takeda’s early-stage development programs" w #WUaSunivs collab w both cos?
Thnx @geochurch for retweet & how best could @WorldUnivAndSch dev a #RealisticVirtualEarthForProteins #ForAgingReversal re
— WorldUnivandSch (@WorldUnivAndSch) October 15, 2025
"Nabla Bio’s AI design and human-relevant wet-lab capabilities" to deploy "across Takeda’s early-stage development programs" w #WUaSunivs collab w both cos? https://t.co/5Viqj1Ym2c
https://x.com/WorldUnivAndSch/
https://x.com/HarbinBook/
https://x.com/scottmacleod/
https://x.com/TheOpenBand/
https://x.com/sgkmacleod/
https://x.com/WUaSPress/
https://www.linkedin.com/
https://www.linkedin.com/
https://www.linkedin.com/
Retweeting
We’re excited to share a new multi-year collaboration with @TakedaPharma, building on the success of our first engagement. Under the agreement, Nabla will receive double-digit millions in upfront and research payments and is eligible for success-based payments exceeding $1…
— Nabla Bio (@nablabio) October 14, 2025
Nabla Bio’s AI design AND human-relevant wet-lab capabilities
Thnx @geochurch for retweet & how best could @WorldUnivAndSch develop a #
"Nabla Bio’s AI design and human-relevant wet-lab capabilities" to deploy "across Takeda’s early-stage development programs" with #WUaSunivs collaborating w both companies?
https://x. com/WorldUnivAndSch/status/
https://x. com/HarbinBook/status/
https://x. com/scottmacleod/status/
https://x. com/TheOpenBand/status/
https://x. com/sgkmacleod/status/
https://x. com/WUaSPress/status/
Retweeting
We’re excited to share a new multi-year collaboration with @TakedaPharma, building on the success of our first engagement. Under the agreement, Nabla will receive double-digit millions in upfront and research payments and is eligible for success-based payments exceeding $1 billion.
The partnership deploys Nabla’s AI-driven JAM platform across Takeda’s early-stage programs to include de novo design of antibodies in parallel for multiple targets, multispecifics, challenging targets, and other custom therapeutics.
Read more below
https://x. com/nablabio/status/
Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
https://www.businesswire. com/news/home/20251014934240/
Press release:
https://x. com/nablabio/status/
quotes from:
"Nabla Bio’s AI design AND human-relevant wet-lab capabilities"
"Multi-year partnership deploys Nabla Bio’s AI design and human-relevant wet-lab capabilities broadly across Takeda’s early-stage development programs"
& regarding especially a #PhysicalDigital #ActualVirtual #RealisticVirtualEarth (and see #PeterNorvig's INCREDIBLE #ToolifyAIWUaS article - https://www.toolify. ai/ai-news/revolutionizing-
https://www.linkedin.com/
https://www.linkedin.com/
https://www.linkedin.com/
*
https://en.wikipedia.org/wiki/Strobilanthes_kunthiana
...
No comments:
Post a Comment